El Instituto de Salud Carlos III es el principal Organismo Público de Investigación (OPI), que financia, gestiona y ejecuta la investigación biomédica en España. Con una trayectoria de más de 20 años de investigación en ciencias de la vida y de la salud y prestación de servicios de referencia, es además el organismo gestor de la Acción Estratégica en Salud (AES) en el marco del Plan Nacional de I+D+I. Adscrito orgánicamente al Ministerio de Ciencia, Innovación y Universidades (Real Decreto 865/2018) y funcionalmente, tanto a este como al Ministerio de Sanidad, Consumo y Bienestar Social (Real Decreto 1047/2018), tiene como misión principal el fomento de la generación de conocimiento científico en ciencias de la salud y el impulso de la innovación en la atención sanitaria y en la prevención de la enfermedad. Situando al paciente y a la ciudadanía en el centro de todos sus objetivos y actividades, fomenta y coordina la investigación Biomédica y ofrece Servicios Científico-Técnicos de la más alta calidad, en colaboración con todos los agentes del Sistema Español de Ciencia, Tecnología e Innovación.

Subcomunidades en esta comunidad

Envíos recientes

Antibodies against the Mycobacterium tuberculosis complex and Brucella spp. in captive and free-living European bison (Bison bonasus) in Poland 

Background: The European bison (Bison bonasus), a symbol of Polish nature, is a protected species that requires active health monitoring. However, conservation efforts are made difficult by the zoonotic diseases such as brucellosis and tuberculosis. Objective: The aim of this study was to screen th...

RAD51 restricts DNA over-replication from re-activated origins 

Eukaryotic cells rely on several mechanisms to ensure that the genome is duplicated precisely once in each cell division cycle, preventing DNA over-replication and genomic instability. Most of these mechanisms limit the activity of origin licensing proteins to prevent the reactivation of origins th...

Effectiveness of the adapted bivalent mRNA COVID-19 vaccines against hospitalisation in individuals aged ≥ 60 years during the Omicron XBB lineage-predominant period: VEBIS SARI VE network, Europe, February to August, 2023 

We conducted a multicentre hospital-based test-negative case-control study to measure the effectiveness of adapted bivalent COVID-19 mRNA vaccines against PCR-confirmed SARS-CoV-2 infection during the Omicron XBB lineage-predominant period in patients aged ≥ 60 years with severe acute respiratory i...

Exposure to residential traffic and trajectories of unhealthy ageing: results from a nationally-representative cohort of older adults 

Background: Traffic exposure has been associated with biomarkers of increased biological ageing, age-related chronic morbidities, and increased respiratory, cardiovascular, and all-cause mortality. Whether it is associated with functional impairments and unhealthy ageing trajectories is unknown. Me...

Epidemiology of reported cases of leptospirosis in the EU/EEA, 2010 to 2021 

Background:Leptospirosis is a zoonotic disease caused by bacteria of the genus Leptospira. Humans are infected by exposure to animal urine or urine-contaminated environments. Although disease incidence is lower in Europe compared with tropical regions, there have been reports of an increase in lept...

Effectiveness and safety of bictegravir/emtricitabine/tenofovir alafenamide in HIV late presenters 

Objectives: The efficacy of BIC/FTC/TAF in HIV late presenters initiating antiretroviral therapy (ART) has not been sufficiently evaluated. Methods: The aim of this study was to assess the effectiveness and tolerability of BIC/FTC/TAF compared to other first-line antiretroviral regimens in treatmen...

Dynamics of the double burden of malnutrition in Guatemala: a secondary data analysis of the demographic and health surveys from 1998-2015 

Objective: We estimated the prevalence and time trends of the double burden of malnutrition (DBM) in Guatemala and explored its occurrence based on socio-demographic factors. Study design: This was a secondary data analysis using information from four Demographic and Health Surveys covering the per...

Circadian rhythm disruption and retinal dysfunction: a bidirectional link in Alzheimer's disease? 

Dysfunction in circadian rhythms is a common occurrence in patients with Alzheimer's disease. A predominant function of the retina is circadian synchronization, carrying information to the brain through the retinohypothalamic tract, which projects to the suprachiasmatic nucleus. Notably, Alzheimer'...

Subthalamic stimulation has acute psychotropic effects and improves neuropsychiatric fluctuations in Parkinson's disease 

Background: Subthalamic nucleus deep brain stimulation (STN-DBS) is a well-established treatment for motor complications in Parkinson's disease (PD). However, its effects on neuropsychiatric symptoms remain disputed. The aim of this study was to evaluate the effects of STN-DBS on neuropsychiatric s...

Relative vaccine effectiveness against COVID-19 hospitalisation in persons aged ≥ 65 years: results from a VEBIS network, Europe, October 2021 to July 2023 

To monitor relative vaccine effectiveness (rVE) against COVID-19-related hospitalisation of the first, second and third COVID-19 booster (vs complete primary vaccination), we performed monthly Cox regression models using retrospective cohorts constructed from electronic health registries in eight E...

Estimation of Improvements in Mortality in Spectrum Among Adults With HIV Receiving Antiretroviral Therapy in High-Income Countries 

Introduction: Mortality rates for people living with HIV (PLHIV) on antiretroviral therapy (ART) in high-income countries continue to decline. We compared mortality rates among PLHIV on ART in Europe for 2016-2020 with Spectrum's estimates. Methods: The AIDS Impact Module in Spectrum is a compartme...

Actualización del coste de vacunar a lo largo de toda la vida en España para el año 2023 

[ES] Fundamentos: En el calendario de vacunación a lo largo de toda la vida del Consejo Interterritorial del Sistema Nacional de Salud (CISNS) se introdujeron cuatro modificaciones importantes en 2023. El objetivo de este estudio fue estimar el coste de la vacunación a lo largo de toda la vida a un...

Evaluation of the Panbio™ COVID-19 IgG rapid test device performance 

Background: The Panbio™ COVID-19 IgG Rapid Test Device ("Panbio™") detects IgG antibodies against the SARS-CoV-2 spike protein from viral infection or vaccination. Objectives: To determine the diagnostic sensitivity and specificity of the Panbio™ professional use test, using fingerstick whole blood...

The Challenges of Vaccine Trial Participation among Underserved and Hard-to-Reach Communities: An Internal Expert Consultation of the VACCELERATE Consortium 

Underserved and hard-to-reach population groups are under-represented in vaccine trials. Thus, we aimed to identify the challenges of vaccine trial participation of these groups in member countries of the VACCELERATE network. Seventeen National Coordinators (NC), each representing their respective ...

Genetic Characterization of Extensively Drug-Resistant Shigella sonnei Infections, Spain, 2021-2022 

In 2022, the United Kingdom reported an increase in drug resistance in Shigella sonnei isolates. We report 33 cases in Spain genetically related to the UK cases and 4 cases with similar antimicrobial resistance profiles infected with genetically distant strains. Our results suggest circulation of m...

Changes in Group A Streptococcus emm Types Associated with Invasive Infections in Adults, Spain, 2023 

An increase in invasive group A Streptococcus infection was detected in the northeast of Spain in November 2022. A postpandemic decline in the diversity of circulating emm types involved in invasive group A Streptococcus was observed, along with the emergence of emm49 in this geographic area.

Situación epidemiológica prepandémica de la campilobacteriosis en España entre los años 2013-2019 

[ES] La campilobacteriosis es la enfermedad gastrointestinal más notificada en la Unión Europea (UE). En este trabajo se analizaron las características epidemiológicas de la campilobacteriosis en España antes de la pandemia de COVID-19.Se realizó un estudio observacional descriptivo retrospectivo e...

Antibiotic Utilization in Hospitalized Children with Bronchiolitis: A Prospective Study Investigating Clinical and Epidemiological Characteristics at a Secondary Hospital in Madrid (2004-2022) 

Bronchiolitis is a viral respiratory infection, with respiratory syncytial virus (RSV) being the most frequent agent, requiring hospitalization in 1% of affected children. However, there continues to be a noteworthy incidence of antibiotic prescription in this setting, further exacerbating the glob...